The ‘PPI medicine’ market exceeded KRW 300 billion

Usage of PPI(proton-pump inhibitor) drugs, well-known reflux esophagitis treatments, is continuously increasing every year.

The annual increase rate was 9.7% for the past 5 years, and their prescriptions exceeded KRW 300 billion for the first time last year. In particular, it was analyzed that esomeprazole-type drugs have been increased by 54.5% annually, accounting for 32.6% of the entire PPI...